Integrating the Pathophysiology and Pharmacogenomics of Essential Hypertension
Integrating the Pathophysiology and Pharmacogenomics of Essential Hypertension
About this item
Full title
Author / Creator
Publisher
Auckland: Wolters Kluwer Health, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Auckland: Wolters Kluwer Health, Inc
Subjects
More information
Scope and Contents
Contents
The results of pharmacogenomics studies on essential hypertension are contrasting. Methodological flaws in study design, patient selection, statistics and analysis may be responsible for these discrepancies. In this article we review the literature on the pharmacogenomics of essential hypertension and provide suggestions for future pharmagenomic st...
Alternative Titles
Full title
Integrating the Pathophysiology and Pharmacogenomics of Essential Hypertension
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2932567611
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2932567611
Other Identifiers
ISSN
1120-9879
E-ISSN
1179-1985
DOI
10.2165/00151642-200613040-00004
